ProQR Therapeutics N.V. Cash Flows From Used In Investing Activities
ProQR Therapeutics N.V. (PRQR) reported Cash Flows From Used In Investing Activities of -EUR 1.02 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-12
- ProQR Therapeutics N.V. cash flows from used in investing activities for the quarter ending 2025-12-31 was -526.00K EUR.
- ProQR Therapeutics N.V. cash flows from used in investing activities for the quarter ending 2025-09-30 was -169.00K EUR, a 101.01% decline year-over-year.
- ProQR Therapeutics N.V. cash flows from used in investing activities for the quarter ending 2025-06-30 was -101.00K EUR.
- ProQR Therapeutics N.V. cash flows from used in investing activities for the quarter ending 2025-03-31 was -224.00K EUR.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -526.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -695.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | -796.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | -1.02M EUR 20-F · filed 2026-03-12 |
| 2025-09-30 | -169.00K EUR 6-K · filed 2025-11-06 | -270.00K EUR derived: sum of 2 quarters · filed 2025-11-06 | -494.00K EUR 6-K · filed 2025-11-06 | -3.28M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | -101.00K EUR 6-K · filed 2025-08-07 | -325.00K EUR 6-K · filed 2025-08-07 | -3.11M EUR derived: sum of 3 quarters · filed 2026-03-12 | 13.60M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | -224.00K EUR 6-K · filed 2025-05-08 | -3.01M EUR derived: sum of 2 quarters · filed 2026-03-12 | 13.70M EUR derived: sum of 3 quarters · filed 2026-03-12 | 13.44M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | -2.79M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 13.93M EUR derived: sum of 2 quarters · filed 2026-03-12 | 13.66M EUR derived: sum of 3 quarters · filed 2026-03-12 | -4.07M EUR 20-F · filed 2026-03-12 |
| 2024-09-30 | 16.71M EUR 6-K · filed 2025-11-06 | 16.45M EUR derived: sum of 2 quarters · filed 2025-11-06 | -1.28M EUR 6-K · filed 2025-11-06 | 3.71M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -267.00K EUR 6-K · filed 2025-08-07 | -18.00M EUR 6-K · filed 2025-08-07 | -13.00M EUR derived: sum of 3 quarters · filed 2026-03-12 | -13.34M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -17.73M EUR 6-K · filed 2025-05-08 | -12.73M EUR derived: sum of 2 quarters · filed 2026-03-12 | -13.07M EUR derived: sum of 3 quarters · filed 2026-03-12 | -13.37M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | 5.00M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 4.66M EUR derived: sum of 2 quarters · filed 2026-03-12 | 4.37M EUR derived: sum of 3 quarters · filed 2026-03-12 | 4.28M EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | -339.00K EUR 6-K · filed 2024-11-07 | -633.00K EUR derived: sum of 2 quarters · filed 2024-11-07 | -722.00K EUR 6-K · filed 2024-11-07 | -703.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -294.00K EUR 6-K · filed 2024-08-08 | -383.00K EUR 6-K · filed 2024-08-08 | -364.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | -610.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -89.00K EUR 6-K · filed 2024-05-09 | -70.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | -316.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | -547.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | 19.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | -227.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | -458.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | -702.00K EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | -246.00K EUR 6-K · filed 2023-11-07 | -477.00K EUR derived: sum of 2 quarters · filed 2023-11-07 | -721.00K EUR 6-K · filed 2023-11-07 | -887.00K EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -231.00K EUR 6-K · filed 2023-08-03 | -475.00K EUR 6-K · filed 2023-08-03 | -641.00K EUR derived: sum of 3 quarters · filed 2023-08-03 | -816.00K EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -244.00K EUR 6-K · filed 2023-05-16 | -410.00K EUR derived: sum of 2 quarters · filed 2023-05-16 | -585.00K EUR derived: sum of 3 quarters · filed 2023-05-16 | -637.00K EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | -166.00K EUR 6-K · filed 2022-02-24 | -341.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | -393.00K EUR derived: sum of 3 quarters · filed 2022-11-09 | -425.00K EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | -175.00K EUR 6-K · filed 2022-11-09 | -227.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | -259.00K EUR 6-K · filed 2022-11-09 | -377.00K EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -52.00K EUR 6-K · filed 2022-08-04 | -84.00K EUR 6-K · filed 2022-08-04 | -202.00K EUR derived: sum of 3 quarters · filed 2022-08-04 | -466.00K EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -32.00K EUR 6-K · filed 2022-05-05 | -150.00K EUR derived: sum of 2 quarters · filed 2022-05-05 | -414.00K EUR derived: sum of 3 quarters · filed 2022-05-05 | -758.00K EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -118.00K EUR 6-K · filed 2022-02-24 | -382.00K EUR derived: sum of 2 quarters · filed 2022-02-24 | -726.00K EUR derived: sum of 3 quarters · filed 2022-02-24 | -924.00K EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | -264.00K EUR 6-K · filed 2021-11-04 | -608.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | -806.00K EUR 6-K · filed 2021-11-04 | -1.04M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -344.00K EUR 6-K · filed 2021-08-05 | -542.00K EUR 6-K · filed 2021-08-05 | -781.00K EUR derived: sum of 3 quarters · filed 2021-08-05 | -813.00K EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -198.00K EUR 6-K · filed 2020-05-07 | -437.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | -469.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | -555.00K EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | -239.00K EUR 6-K · filed 2021-02-25 | -271.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | -357.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | -580.00K EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | -32.00K EUR 6-K · filed 2020-11-16 | -118.00K EUR derived: sum of 2 quarters · filed 2020-11-16 | -341.00K EUR 6-K · filed 2020-11-16 | -368.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -86.00K EUR 6-K · filed 2020-08-06 | -309.00K EUR 6-K · filed 2020-08-06 | -336.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -435.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | -223.00K EUR 6-K · filed 2020-05-07 | -250.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -349.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -531.00K EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | -27.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | -126.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | -308.00K EUR derived: sum of 3 quarters · filed 2021-03-24 | -312.00K EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | -99.00K EUR 6-K · filed 2019-11-12 | -281.00K EUR derived: sum of 2 quarters · filed 2019-11-12 | -285.00K EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | -182.00K EUR 6-K · filed 2019-08-07 | -186.00K EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | -121.00K EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | -48.00K EUR 6-K · filed 2018-08-08 | -93.00K EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | -2.54M EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | -1.32M EUR 20-F · filed 2018-03-30 |